Event Detail



Current On-Demand CE Offerings

Title: Peer Review 101

ACPE UAN: 0202-9999-23-271-H99-P

CEUs: 0.10 – 1 contact hour of CPE credit

Activity type: Knowledge-based

Target Audience: Pharmacists

Initial release date: June 6, 2023

Expiration date: June 6, 2026 – No credit can be earned after this date

Fees for obtaining CE credit: SPPCP Members – free; Non-members – $35

Session Description:

Interested in peer review but not sure where to start? This session will provide an overview of the peer review process, including the value of peer review to your career, to authors, and to the profession. As a step-by-step guide to expert peer review, this session will provide first-time and experienced peer reviewers with resources for preparing an effective and efficient review report.

Learning Objectives:

At the completion of this activity, participants will be able to:

  • Describe the peer review process, including why it is important and how to get involved.
  • Discuss strategies for performing an effective and efficient peer review.

Faculty:

Laura Meyer-Junco, PharmD, BCPS, CPE, FASCP, Clinical Assistant Professor, University of Illinois College of Pharmacy

Disclosures:

Laura Meyer-Junco, PharmD, BCPS, CPE, FASCP has nothing to disclose.

 

Title: Buprenorphine Basics for Pain Management

ACPE UAN: 0202-9999-23-214-H08-P

CEUs: 0.10 – 1 contact hour of CPE credit

Activity type: Knowledge-based

Target Audience: Pharmacists

Initial release date: October 24, 2023

Expiration date: October 24, 2026 – No credit can be earned after this date

Fees for obtaining CE credit: SPPCP Members – free; Non-members – $35

Session Description:

Despite growing use, many pharmacists and providers lack the knowledge and experience to use buprenorphine properly for pain management. The goal of this session is to increase familiarity and comfort with the basics of using buprenorphine for pain management. Session attendees will gain a better understanding of how buprenorphine can be used for pain, its place in therapy, proper patient selection, and how to initiate and titrate buprenorphine safely.   

Learning Objectives:

At the completion of this activity, participants will be able to:

  • Describe buprenorphine’s pharmacology related to pain management. 

  • Identify indications for buprenorphine use in pain management. 

  • List practical considerations for selecting buprenorphine for pain management. 

Faculty:

Craig Yon, PharmD, PhC, BCACP, Clinical Pharmacist, University of New Mexico Pain Consultation and Treatment Center, Albuquerque, NM 

Disclosures:

Craig Yon, PharmD, PhC, BCACP has nothing to declare.

 

Title: Acute Pain Treatment for Patients Taking Buprenorphine

ACPE UAN: 0202-9999-23-217-H08-P

CEUs: 0.10 – 1 contact hour of CPE credit

Activity type: Knowledge-based

Target Audience: Pharmacists

Initial release date: October 24, 2023

Expiration date: October 24, 2026 – No credit can be earned after this date

Fees for obtaining CE credit: SPPCP Members – free; Non-members – $35

Session Description:

Clinicians are more frequently facing challenges managing acute pain in patients taking buprenorphine for pain or opioid use disorder. The goal of this session is to improve pain management for patients using buprenorphine products by increasing understanding of strategies to treat acute pain and improve outcomes during care transitions. The speakers present in-depth information on pharmacokinetic properties of buprenorphine, including comparison of receptor occupancy to other opioids, and use simulated patient cases to demonstrate how to approach the use of buprenorphine along with full agonist opioids for acute pain. The speakers address knowledge gaps on perioperative buprenorphine management and provide strategies for addressing buprenorphine when patients transition to end-of-life care. 

Learning Objectives:

At the completion of this activity, participants will be able to:

  • Define the challenges associated with treating acute pain with other opioids in patients taking buprenorphine. 

  • Compare strategies for managing acute pain in patients on low- and high-doses of buprenorphine. 

  • Summarize considerations for managing buprenorphine in the perioperative setting and transitions of care, including hospice and end-of-life. 

Faculty:

Maximillian Stevenson, PharmD, MA, BCPS, Palliative Care Pharmacist – Clinical Specialist, MedStar Health Washington Hospital Center 
Michael Smith, PharmD, FCCP, BCPS, Clinical Pharmacist, Pain and Palliative Care, University of Michigan Health 

Disclosures:

Maximillian Stevenson, PharmD, MA, BCPS and Michael Smith, PharmD, FCCP, BCPS have nothing to declare.

Title: Buprenorphine for Pain in Patients with Tolerance to Full-Agonist Opioids

ACPE UAN: 0202-9999-23-218-H08-P

CEUs: 0.10 – 1 contact hour of CPE credit

Activity type: Knowledge-based

Target Audience: Pharmacists

Initial release date: October 24, 2023

Expiration date: October 24, 2026 – No credit can be earned after this date

Fees for obtaining CE credit: SPPCP Members – free; Non-members – $35

Session Description:

Off-label use of moderate- and high-dose buprenorphine products for pain management is growing, yet many clinicians are uncomfortable with the logistics of employing a buprenorphine micro-initiation technique to rotate patients tolerant to full-agonist opioids. The goal of this session is to promote a better understanding of buprenorphine micro-initiation for pain management. The speaker reviews different micro-initiation techniques and considerations for using different buprenorphine dosage forms to perform the micro-initiation. Simulated patient cases are used to demonstrate strategies for micro-initiation in a variety of clinical settings and scenarios. 

Learning Objectives:

At the completion of this activity, participants will be able to:

  • Recognize the differences in mu-opioid receptor binding affinity among common full agonist opioids and buprenorphine and their importance in micro-initiation. 

  • Review the different formulations of buprenorphine, their role in micro-initiation, and limitations of each. 

  • Compare different micro-initiation techniques and review of published literature. 

Faculty:

Megan Mitchell, PharmD, MS, Clinical Pharmacy Specialist, Pain and Palliative Care, University of Kentucky HealthCare 

Disclosures:

Megan Mitchell, PharmD, MS has nothing to declare.

 

 

Accreditation is provided by The American Pharmacists Association. The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education.

Interested in pursuing CPE accreditation for an upcoming SPPCP educational activity?

Submit proposals using our Podcast or Webinar submission form

Residents, students, fellows, or other learners seeking CPE accreditation MUST identify a preceptor mentor to co-present or oversee development of the activity. The preceptor mentor must be included on the submission form and submit an updated CV and COI disclosure.

Follow the timelines below to plan accordingly for the CPE accreditation process. Contact continuinged@palliativepharmacist.org with questions.

Times given are in advance of the planned CE date 

Podcast 

Webinar – Live or On-Demand 

Written 

Live/ Conference 

eLearning Module 

CE proposal submitted to SPPCP for consideration 

4 months 

4 months 

6 months 

6 months 

8 months 

Approved faculty and proposal submitted to CPE accreditor 

3 months 

3 months 

4 months 

5 months 

6 months 

Draft of materials due for review 

1.5 months 

1.5 months 

2 months 

2 months 

3 months 

Materials finalized 

3 weeks 

3 weeks 

3 weeks 

1 month 

1 month 

 

Join SPPCP to access on-demand CE free with membership. Membership options available here.